TGen, Persistent Developing Commercial Version of Biospecimen Management System | GenomeWeb

NEW YORK (GenomeWeb News) – Persistent Systems and the Translational Genomics Research Institute announced they are developing a commercial version of a biospecimen management system.

Called Bio4D, initial versions of the software have been used at TGen in research into the underlying causes of diseases. The partners will now develop a commercial version to manage the collection, processing, storage, distribution, and analysis of biospecimens including blood, DNA, and tissue samples, such as samples from cancer biopsies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

University of the Republic postdoc Victor Morais says researchers should be careful of the open access journals they choose to publish in.

If science funding agencies can talk tough about sexual harassers, shouldn't they also put their talk into action?

In PNAS this week: researchers identify the characteristic genomic features of clear cell renal cell carcinoma, and more.

A technology that has the potential to make species go extinct could be used against the Zika virus.